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Abstract
Background: Cigarette smoke (CS) exposure impaired plasma lipid profiles by modification of apolipoproteins.
Hydrogen (H2) has been proved effective on reducing oxidative stress or improving HDL functionalities in animal
models or metabolic syndrome volunteers. This study was undertaken to explore the effects of CS exposure on
reverse cholesterol transport (RCT) and the antioxidative effects of H2 treatment against CS exposure in mice
transgenic for human cholesteryl ester transfer protein (CETP).
Methods: [3H]-cholesterol-laden macrophages were injected intraperitoneally into mice, and the samples of blood,
bile, liver, and feces were collected for radioactivity determination to evaluate RCT. [3H]-cholesterol-laden macrophages
were incubated with HDL isolated from different groups of mice, and the samples of cell medium supernatants were
collected for evaluating the HDL functionality to elicit cholesterol efflux.
Results: CS exposure significantly decreased plasma HDL cholesterol level (HDL-C) by 22 % and increased LDL
cholesterol level (LDL-C) by 21 % compared with the control group (p < 0.05, p < 0.01), while H2 treatment significantly
improved the CS-impaired levels of TC, LDL-C and HDL-C by 10, 27 and 31 %, respectively, compared with the CS group
(p < 0.05, p < 0.01 and p < 0.05). Besides, CS exposure significantly decreased [3H] tracer concentrations in liver, bile and
feces by 17, 35 and 48 %, respectively, compared with the control group (p < 0.05 for liver and feces), while H2 treatment
significantly improved them by 21, 72 % and 89 %, respectively, compared with the CS group (all p < 0.05). Furthermore,
CS exposure significantly decreased the HDL functionality to elicit cholesterol efflux by 26 % (p < 0.05), while
H2 treatment also improved it by 32 % (p < 0.05). We did not find any significant alterations in protein
expressions of RCT involved genes.
Conclusions: These findings provided direct evidence supporting the notion that CS exposure in vivo impairs
plasma lipid profiles, HDL functionalities and macrophage-to-feces RCT pathway in CETP transgenic mice, all
of which can be minimized by treatment of H2-saturated saline.
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Background
Reverse cholesterol transport (RCT) is generally defined as
cholesterol efflux from peripheral cells to plasma HDL
uptaked by hepatocytes for utilization, direct secretion into
bile and feces disposal [1, 2]. Therefore, the intact HDL
functionalities have been believed to be atheroprotective in
atherosclerosis development [3]. Cholesteryl ester transfer
protein (CETP) facilitates removal of cholesterol ester from
plasma HDL in exchange for triglycerides from low-density
lipoproteins or very low-density lipoproteins (LDL or
VLDL) [4, 5]. Since wild C57BL/6 J mouse lacks CETP
gene necessary for simulating human lipid profiles [6], hu-
man CETP transgenic heterozygous mice with a C57BL/6J
background were used in the present study.
Both animal and human studies have demonstrated that
cigarette smoke (CS) exposure significantly increased levels
of plasma total cholesterol (TC), total triglyceride (TG),
LDL-cholesterol (LDL-C), but decreased the level of HDL-
Cholesterol (HDL-C) [7–9]. A few in vitro studies revealed
that CS exposure promoted the modification of lysine
amino residue on HDL which would thus lose the func-
tionality to stimulate cholesterol efflux from macrophages
[10, 11]. On the other hand, our previous studies demon-
strated that H2-rich water or H2-saturated saline decreased
aortic atherosclerosis, improved HDL functionalities, and
reduced the oxidative stress in animal models or metabolic
syndrome volunteers [12–14]. Based on these findings, we
proposed that CS exposure in vivo impairs HDL function-
alities or RCT pathway in CETP transgenic mice, and that
the impairment by CS exposure could be minimized by
treatment of H2-saturated saline.
Methods
Materials
Acetylated low density lipoprotein particles (ac-LDL) were
prepared from 48 mL of fresh blood from a healthy volun-
teer by sequential ultracentrifugation [15]. [3H]-labeled-
cholesterol was purchased from PerkinElmer (Waltham,
MA, USA). Enzymatic assay kits for plasma lipid determi-
nations were purchased from BioSino (Beijing, China). Kit
for measuring formation of thiobarbituric acid reactive
substances (TBARS) was from Jiancheng Biochemistry
(Najing, China). All antibodies were purchased from
Abcam (Cambridge, MA, USA). Commercial Taishan
cigarettes (11 mg of tar,1.1 mg of nicotine,12 mg of carbon
monoxide, Shandong, China) are used in the present study.
Animals and grouping
Mice of human CETP transgenic strain with a C57BL/6J
background were presented by Dr. Xiancheng Jiang
(Department of Anatomy and Cell Biology, SUNY
Downstate Medical Center). All CETP transgenic mice
were offspring littermates of CETP heterozygous mice.
Seventy-two male CETP transgenic mice, 10 weeks old,
fed a chow diet (Keaoxieli Co. LTD, Beijing, China) and
water ad libitum, were housed in a temperature and
humidity controlled room with a 12/12 h light–dark
cycle. Mice were exposed to either room air or CS at five
cigarettes/d and 5 d/wk for 12 weeks. During the last
four weeks the mice were intraperitoneally injected with
H2-saturated saline or vehicle (saline) once daily. All
animal experiments were conducted in accordance with
the Guidelines for Care and Use of Laboratory Animals
of Taishan Medical University, and this study was
approved by the Laboratory Animals’ Ethical Committee
of Taishan Medical University.
The animals were randomly divided into the control
group, the H2 group (H2-saturated saline treated,
5 mL/kg/d), the CS group (CS exposed) and the H2 +
CS group (H2-saturated saline treated plus CS exposed)
(n = 18). In addition, a group of eight C57BL/6J mice were
added in the experiment of plasma lipid determination to
verify the phenotype of CETP transgenic mice.
Equipment for CS exposure
Cages for CS exposure were re-designed according to
Escolar et al. [16]. Briefly, the cages (42.5 × 26.6 × 19 cm)
were equipped with a disposable filter cover having 15
10-mm holes that enabled inside air to be flown out of
the cages and thus to be continuously renewed. CS
was produced by cigarette burning and introduced
into the chamber with airflow generated by a 50 mL
medical syringe manipulated by a researcher, at a rate
of 125 mL/min. Five cigarettes were smoked one by
one within 20 min. A rodent ventilator (Ugo Basile,
Shanghai, China) was used to provide fresh room air
for dilution (1:8) of smoke stream.
Preparation of H2-saturated saline
H2 was produced with a self-designed apparatus and im-
mediately dissolved into normal sterile saline to supersatu-
rated concentration for 2 h under high pressure (0.6 MPa).
H2-saturated saline, stored under atmospheric pressure
and 4 °C, was freshly prepared every 3 days to ensure a
constant H2 concentration of not less than 0.6 mM.
Preparation of [3H]-cholesterol-laden macrophages
Briefly, as described by Yu et al. [17], Raw264.7 cells
were incubated with [3H]-cholesterol (5 μCi/mL) and
ac-LDL (100 μg/mL) for 48 h, and were then harvested
at 1.0 × 106 cells/mL for intraperitoneal injection into
mice. The ratio of the intracellular [3H]-cholesterol
radioactivity to the total [3H]-cholesterol radioactivity
was more than 95 %, which indicated the harvested
macrophages had already uptaken 95 % of the total
[3H]-cholesterol and thus were in good condition.
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RCT assay by [3H]-labeled-cholesterol tracing
After CS exposure or H2-saturated saline treatment, nine
mice from each group were injected intraperitoneally with
0.5 mL of [3H]-cholesterol-laden macrophage suspension.
At 0, 6, 12 and 24 h after injection, blood was collected
from the retro-orbital sinus with heparinized capillary tubes
without dietary exposure for 12 h. The mice were then
anesthetized with aether and sacrificed at 24 h after injec-
tion. Samples of bile, liver, and feces were collected, mea-
sured or weighed, and stored at −80 °C for radioactivity
determination (n =9). Plasma samples were isolated from
blood by centrifugation for liquid scintillation counting.
Cholesterol efflux from macrophages
The cholesterol efflux experiments were performed accord-
ing to Smith et al. [18]. HDL was isolated from each group
of mice by sequential ultracentrifugation. Raw264.7 macro-
phages at 50 % confluence were co-cultured with acLDL
(100 μg/mL) containing [3H]-cholesterol (1 μCi/mL) in
RGGB (RPMI 1640 supplemented with 50 mM glucose,
2 mM glutamine and 0.1 % BSA) for 30 min. The macro-
phages were washed with PBS containing 0.1 % BSA, equil-
ibrated with RGGB for 24 h, and cultured for 16 h in the
presence of 300 μM dibutyryl cyclic AMP (dBcAMP). The
culture medium was then replaced with RGGB containing
200 μg/mL of HDL isolated from each group of mice. The
medium supernatants were collected for radioactivity deter-
mination after 12 h of incubation. The macrophages were
washed and dissolved in 0.4 mL of 0.1 M sodium hydrox-
ide, and lysate radioactivity was measured. The percentage
of cholesterol efflux could be calculated by dividing the
supernatant-derived radioactivity by the sum of the
supernatant-derived radioactivity and the intracellular
macrophage radioactivity (n = 6).
LDL oxidation determination
In the presence or absence of the HDL (200 μg/mL)
isolated from each group of mice, LDL (100 μg/mL)
isolated from a volunteer was incubated with freshly
prepared copper sulfate (10 μmol/L) at 37 °C for 2 h. The
extent of LDL oxidation was evaluated by measuring
formation of TBARS (n = 6) [19].
Preparation of mice peritoneal macrophages
Nine mice from each group were sacrificed and intraper-
itoneally injected each with 5 mL of sterile PBS, massa-
ging gently the abdomen for 5 min. PBS was then drawn
out and centrifugated at 1500 rpm for 10 min. The cells
were collected and frozen at −80 °C for Western blot.
Real-time PCR
Cellular RNA was extracted with TRIZOL Reagent
(Invitrogen, USA). cDNA was synthesized using Reverse
Transcriptase (TianGen Biotech, China). Real-time PCR
was performed using the SYBR-green PCR master mix kit
(TianGen Biotech, China). The data were analyzed by
using Rotor-gene Q software (ver. 1.7). Relative mRNA
levels were calculated by the 2-DDCt method (n = 6). All
primers used in this study were listed in Table 1.
Western blot
Tissue proteins were separated by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE), and the
proteins were transferred onto polyvinylidene fluoride
(PVDF) membrane. Relative expression levels of SRBI,
ABCG5, CYP7A1, LDLR and ABCA1/G1 were calculated
with reference to β-actin (n = 5 for CYP7A1 and ABCG5,
n = 3 for others). All protein bands were quantified using
Image-Pro Plus software (ver. 6.0).
Statistical analysis
All results were expressed as mean ± standard deviation
(S.D). To compare the means between groups, One-way
Table 1 Primers used for real-time PCR
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analysis of variance test (ANOVA) was performed. Prob-
ability values less than 0.05 were considered significant.
Results
Neither CS exposure nor H2 treatment affects mice body
weights
After twelve weeks of CS exposure and four weeks of H2
treatment, we compared the data of body weight between
different groups at week 12, but did not find any remark-
able differences between the control and the CS group, or
between the CS and the H2 + CS group (Table 2).
CS exposure impairs plasma lipid profiles whereas H2
treatment improves
To ensure that model making of CETP transgenic mice
was trustworthy, we determined the plasma lipid profiles
of a group of the eight C57BL/6 J mice, and found that
they were significantly different from those of the control
group of CETP transgenic mice (p < 0.01). We also found
that CS exposure significantly decreased plasma HDL chol-
esterol level (HDL-C) by 22 % and increased LDL choles-
terol level (LDL-C) by 21 % compared with the control
group (p < 0.05, p < 0.01, respectively), while H2 treatment
significantly improved the CS-impaired levels of TC, LDL-
C and HDL-C by 10 %, 27 % and 31 %, respectively, com-
pared with the CS group (p < 0.05, p < 0.01 and p < 0.05,
respectively) (Fig. 1).
CS exposure impairs RCT pathway which can be
minimized by H2 treatment
A classic [3H]-labeled-cholesterol tracing assay was
employed to evaluate the effects of CS or H2 on RCT. As
shown in Fig. 2, the plasma radioactivity percentages of
the total injection did not differ significantly from each
other at each time point (Fig. 2a). Nevertheless, the liver
radioactivity percentage of the total injection in the CS
group was significantly decreased by 17 % compared with
the control group (p < 0.05), while the percentage in the
H2 + CS group was significantly increased by 21 % com-
pared with the CS group (p < 0.05) (Fig. 2b). In addition,
the bile radioactivity percentage in the CS group was de-
creased by 35 % compared with the control group, while
the percentage in the CS +H2 group was significantly in-
creased by 72 % compared with the CS group (p < 0.05)
(Fig. 2c). Moreover, the fecal radioactivity percentage in
the CS group was significantly decreased by 48 % com-
pared with the control group (p < 0.05), while the percent-
age in the CS +H2 group was significantly increased by
89 % compared with the CS group (p < 0.05) (Fig. 2d).
CS exposure impairs HDL functionalities which can be
minimized by H2 treatment
Of all the functionalities, HDL’s protection against LDL
oxidation and the functionality to promote cholesterol
efflux from peripheral macrophages are very important
for RCT pathway. Therefore, we firstly determined
plasma TBARS and found that CS exposure significantly
increased TBARS formation by 64 % compared with the
control group, while H2 treatment significantly de-
creased by 53 % compared with the CS group (Fig. 3a).
We also determined plasma superoxide dismutase
(SOD) levels by Enzyme-linked immunosorbent assay,
but did not find any remarkable alterations (Fig. 3b).
When determining the HDL’s functionality to elicit the
cholesterol efflux from [3H]-cholesterol-laden macro-
phages in vitro, in the presence of cAMP in cell culture
medium, we found that CS exposure significantly de-
creased the efflux by 26 % compared with the control
group (p < 0.05), while H2 treatment also significantly fa-
cilitated it by 32 % compared with the CS group (p <
0.05) (Fig. 3c).
Neither H2 treatment nor CS exposure significantly alters
the expressions of RCT related genes
To exclude other possibilities of the underlying molecular
mechanisms of H2 or CS effect on RCT, the expressions
of key cholesterol transporters and cholesterol metabolic
enzymes from hepatocytes or peritoneal macrophages
were measured by real-time PCR or Western blot. As
shown in Fig. 4, although H2 + CS treatment significantly
up-regulated the mRNA expressions of CYP7A1 and
ABCG5 by 294 % and 164 %, respectively, compared with
the CS group (Fig. 4a), but neither H2 treatment nor CS
exposure significantly altered the hepatic protein expres-
sions of CYP7A1, ABCG5, LDLR and SRBI compared
with the CS group or the control group (Fig. 4b–e).
Besides, when determining the expressions of the choles-
terol transporters from peritoneal macrophages, we also
found that neither H2 treatment nor CS exposure signifi-
cantly altered the protein expressions of ABCA1 and
ABCG1 compared with the CS group or control group by
Western blot (Fig. 4f–g).
Discussion
Cigarette smoking releases a complex mixture of more
than 4,700 chemical constituents [20], including alde-
hydes which are risky constituents for atherosclerosis
development. Freeman et al. reported that aldehydes
Table 2 Mice body weight comparisons
Groups Week0 week8 Week12 P value
Control 28.1 ± 0.81 29.5 ± 1.01 31.0 ± 1.81
H2 27.5 ± 0.16 28.4 ± 0.37 29.6 ± 0.81 0.108
*
CS 28.1 ± 0.47 28.9 ± 1.24 30.1 ± 0.93 0.344*
H2 + CS 29.1 ± 0.63 29.6 ± 0.61 30.3. ± 1.39 0.819
#
The p-values are calculated from the body weight data between different
groups at week12. Values were indicated as means ± S.D. (n = 18). *Compared
with the control group; #: Compared with the CS group
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from CS react with lysine residues of lipoproteins, giving
rise to adducted molecules in the presence of MDA [10].
Additionally, studies revealed that human and rat cigarette
smokers accumulate more macrophages in developing
lesions of thoracic and abdominal aortas than non-
smokers [21, 22].
Evidence in a variety of biomedical fields has proved that
H2 acts as a feasible therapeutic strategy in different
disease models [23–25]. Ohsawa et al. reported that oral
consumption of H2 rich water prevented atherosclerosis in
apoE-knockout mice fed a chow diet, primarily through
decreasing the oxidative stress level in vivo [23, 26]. Our
previous studies in animal models and metabolic syn-
drome volunteers demonstrated that H2 supplementation
decreased aortic atherosclerosis [12], reduced oxidative
stress, improved hyperlipidemia-injured HDL functionality
to stimulate macrophage cholesterol efflux [13, 14].
Consistent with previous studies [9, 27, 28], the current
study demonstrated that CS exposure could impair the
plasma lipid profiles. Interestingly, we also found that H2
treatment significantly improved the levels of plasma
HDL-C, LDL-C and TC compared with the CS group.
These results recommended us that CS exposure or H2
treatment might alter the levels of plasma lipids through
affecting apolipoprotein structures or enzyme activities on
apolipoproteins. Considering that H2 helps to reduce oxi-
dation stress [12–14], we proposed that H2 prevents
certain CS constituents, such as aldehydes, from reacting
with apolipoproteins and impairing their functionalities
[10]. In other words, before H2 treatment CS exposure
might impair apolipoproteins on HDL and (V) LDL parti-
cles, thus preventing cholesterol uptake from peripheral
macrophages to HDL particles and the hepatic cholesterol
transfer from (V) LDL particles to hepatocytes via hepatic
LDLR or SRBI, leading to a significantly lowered level of
HDL-C and increased levels of TC and LDL-C. Whereas,
after H2 treatment this antioxidant significantly minimized
the impairment of plasma lipid profiles, the metabolism of
Fig. 1 Comparisons between plasma lipid profiles of different groups of mice. The determined lipid profiles included the levels of plasma total
cholesterol (Panel a), triglyceride (Panel b), HDL-cholesterol (Panel c) and LDL-cholesterol (Panel d). C57 represents the group of eight C57BL/6J
mice which were used to testify the phenotype of CETP transgenic mice. Values were expressed as mg per deciliter (means ± S.D, n = 8). Signifi-
cantly different from respective control: *p < 0.05; **p < 0.01
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which might be attributable to H2 antioxidation for CS-
impaired apolipoproteins. Nevertheless, in view of the fact
that H2 did not have any beneficial effects on non-
smokers in this study, H2 probably works as a potent anti-
oxidant for oxidative stresses but has little beneficial effect
on normal conditions.
The current study also demonstrated that CS exposure
reduced the accumulation concentrations of [3H]-tracer
in liver, gallbladder bile and feces compared with the
control group (Fig. 2). In addition, CS exposure not only
increased the plasma MDA level but also impaired the
functionality of HDL to elicit macrophage cholesterol
efflux (Fig. 3). Whereas, nearly all these CS impairments
could be minimize by H2 treatment. Then, what could
be the most possible underlying mechanism for the im-
paired RCT pathway in the present study? And what is
the role of H2 throughout the whole impairment of CS?
As is well known, normal plasma HDL helps to
decrease the risk of atherosclerotic cardiovascular dis-
ease. However, as a result of oxidative stress, HDL
Fig. 2 Macrophage-to-feces RCT assay in CETP transgenic mice. Plasma, bile, liver tissue, and feces was isolated or collected for radioactivity
determination. At 0, 6,12 and 24 h after injection, blood samples from each group were collected from the retro-orbital sinus for radioactivity de-
termination (Panel a). The levels of 3H-labeled cholesterol in liver (Panel b), bile (Panel c) and feces (Panel d) from each group were also deter-
mined by liquid scintillation counting. Values were expressed as the percentages of the total injected radioactivity (means ± S.D, n = 6 for plasma,
n = 9 for liver, bile and feces). Significantly different from respective control: *p < 0.05
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particles may undergo dramatic alterations in structure
or composition, losing normal biological activities pro-
gressively [29, 30]. Such HDL particles cannot protect
LDL against oxidation, instead, they turn out to be a
kind of dysfunctional HDL and play a proatherogenic
role in RCT pathway [30]. McCall et al. also reported
that CS exposure could induce a cross-linking of apoli-
poprotein A1 [31], giving rise to HDL conformational al-
teration [10, 32]. Besides, the oxidative stress caused by
CS exposure has been thought to be associated with
plasma antioxidant depletion [33]. It was also reported
that volunteer smokers’ plasma MDA levels, a biomarker
most frequently used to measure oxidative stress, were
enhanced significantly compared with nonsmokers [34].
Therefore, in the present study it was very likely that CS
constituents, such as aldehydes, reacted with MDA to
form adducts on HDL particles [10], impairing their
functionalities and the subsequent RCT pathway. Based
on these, it might be concluded that CS constituents
impair HDL functionality to stimulate cholesterol efflux
and its property to protect against LDL oxidation, and that
H2 probably helps to prevent MDA to react with lysines of
apolipoproteins [10] on HDL particles, thus keeping the
HDL functionalities intact upon CS exposure.
Although CS-impaired HDL might uptake less choles-
terol from peripheral macrophages, leading to the impair-
ment of lipid profiles, the expressions of key cholesterol
transporters and enzymes in hepatocytes or peritoneal
macrophages also contribute the lowered or increased
levels of plasma HDL-C, TC and LDL-C. To exclude this
possibility, we investigated the possible molecular mecha-
nisms for our results (Fig. 4). CYP7A1, the primary rate-
limited enzyme in the synthesis of bile acid, is responsible
for the main consumption of liver cholesterol. The secre-
tion of bile acid is mediated by ABCG5. LDL Receptors
(LDLR) expressed in hepatocytes bind with apolipoprotein
E or B, and promote the uptake of cholesterol-containing
(V) LDL in hepatocytes. Both ABCA1 or ABCG1 expressed
in peripheral macrophages mediates cholesterol efflux to
lipid-poor apolipoproteins or mature HDL, respectively.
However, as shown in Fig. 4, we did not find that any sig-
nificant alterations of the expressions of CYP7A1, ABCG5,
SRB1, LDLR ABC-A1 or ABC-G1 expressed in hepatocytes
or peritoneal macrophages. Thus, we might conclude that
the effects of CS exposure on RCT and the antioxidative
effects of H2 treatment against CS exposure are primarily
through impairing or improving the functionalities of HDL,
rather than enhancing the protein expressions of choles-
terol transporters and cholesterol metabolic enzymes along
RCT pathway.
Nevertheless, this study has a list of limitations. Firstly,
to further characterize the inner action mechanism of H2
on CS-impaired HDL particles, tandem mass spectrom-
etry should be used to elucidate what kinds of peroxide
components on HDL particles had been derived from CS
impairment and the mechanism of how H2 reacts with
these derivatives. Secondly, it is well known that lipid-free
apoA-I is the lipid acceptor for ABCA1-mediated choles-
terol efflux [35–37], while SRBI [38] and ABCG1 [39, 40]
are identified as mediators of cholesterol efflux to mature
HDL. It remains to be further investigated which apolip-
proteins or cholesterol transporters should be responsible
for the result of cholesterol efflux in this study. Thirdly, a
lot of interventions of nutraceuticals have already been
investigated on lipid disorders beyond pharmacological
interventions [41]. The beneficial actions of nutraceuticals
Fig. 3 Measurements of HDL functionalities. Levels of MDA, thiobarbituric acid reactive substances (TBARS), were measured to assess the extent
of LDL oxidation (Panel a). Plasma SOD levels was determined (Panel b). [3H]-cholesterol-laden macrophages were co-cultured with HDL from
each group to determine the HDL functionality to promote cholesterol efflux (Panel c). [3H] cholesterol efflux % was calculated by dividing the
supernatant-derived radioactivity by the sum of the supernatant-derived radioactivity and the intracellular macrophage radioactivity. Values were
indicated as means ± S.D. (n = 6). Significantly different from respective control: *p < 0.05
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Fig. 4 (See legend on next page.)
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may be related to several mechanisms such as endothelial
function amelioration [42], antithrombotic activities [43]
and improving lipid metabolism mechanisms [44]. Unlike
these nutraceuticals, in view of the fact that the problem
for maintenance of H2 saturated concentration in cell
culture medium has not been addressed, the action mech-
anism of H2 still remains poorly understood. Finally,
although one of our previous studies demonstrated that
supplementation with H2-rich water decreases serum
LDL-C, improves dyslipidemia-injured HDL functional-
ities and reduces the oxidative stress, and concluded that
H2 might have a beneficial role in prevention of metabolic
syndrome [13], further H2 atheroprotective studies on
humans should still be required to fully understand the
mechanism of H2 beneficial effects on lipid disorders.
In conclusion, our findings suggested that CS exposure
in vivo impairs the plasma lipid profiles, the HDL func-
tionalities and the subsequent macrophage-to-feces RCT
pathway in CETP transgenic mice, and that H2 treat-
ment decreases plasma MDA level, thereby prevents
apolipoproteins to react with MDA, and thus minimizes
the CS-impaired RCT pathway.
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